In anticoagulant therapy, what does "CHADS2" indicate?

• A. Chronic heart failure, Hypertension, Age ≥75, Diabetes, Stroke history
• B. Chronic hypertension, Age ≥70, Drug interaction, Stroke incidence, Diabetes
• C. Congenital heart disease, High blood pressure, Age factor, Diabetes history, Stroke management
• D. Cholesterol levels, Hypertension, Age adjustment, Diabetes, Social history

Answer: (A)

The CHADS2 scoring system is specifically designed to assess the risk of stroke in patients with atrial fibrillation and aids in determining the appropriate anticoagulant therapy. The components of the CHADS2 score are each linked to factors that indicate an increased risk of stroke:

• Chronic heart failure contributes to cardiovascular morbidity, heightening stroke risk.

• Hypertension is a significant risk factor for both stroke and cardiovascular events.

• Age ≥ 75 years increases the likelihood of both stroke and other complications.

• Diabetes is known to elevate the risk of cardiovascular disease and stroke.

• A history of stroke or transient ischemic attack (TIA) dramatically raises the risk of future strokes.

The scoring system assigns one point for chronic heart failure, hypertension, age ≥ 75, and diabetes, while a history of stroke or TIA is assigned two points. The total CHADS2 score then helps clinicians make informed decisions regarding the need for anticoagulation therapy.

Understanding this scoring system is crucial for healthcare providers in order to effectively reduce the risk of thromboembolic events in patients with atrial fibrillation.